Proteasome Subunits Involved in Neurodegenerative Diseases

被引:27
|
作者
Fernandez-Cruz, Ivan [1 ]
Reynaud, Enrique [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Ave Univ 2001, Cuernavaca 62218, Morelos, Mexico
关键词
Proteasome subunits; Parkinson's disease; Alzheimer's disease; Huntington's disease; Amyotrophic lateral sclerosis; Spinocerebellar ataxia;
D O I
10.1016/j.arcmed.2020.09.007
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The ubiquitin-proteasome system is the major pathway for the maintenance of protein homeostasis. Its inhibition causes accumulation of ubiquitinated proteins; this accumulation has been associated with several of the most common neurodegenerative diseases. Several genetic factors have been identified for most neurodegenerative diseases, however, most cases are considered idiopathic, thus making the study of the mechanisms of protein accumulation a relevant field of research. It is often mentioned that the biggest risk factor for neurodegenerative diseases is aging, and several groups have reported an age-related alteration of the expression of some of the 26S proteasome subunits and a reduction of its activity. Proteasome subunits interact with proteins that are known to accumulate in neurodegenerative diseases such as alpha-synuclein in Parkinson's, tau in Alzheimer's, and huntingtin in Huntington's diseases. These interactions have been explored for several years, but only until recently, we are beginning to understand them. In this review, we discuss the known interactions, the underlying patterns, and the phenotypes associated with the 26S proteasome subunits in the etiology and progression of neurodegenerative diseases where there is evidence of proteasome involvement. Special emphasis is made in reviewing proteasome subunits that interact with proteins known to have an age related altered expression or to be involved in neurodegenerative diseases to explore key effectors that may trigger or augment their progression. Interestingly, while the causes of age-related reduction of some of the proteasome subunits are not known, there are specific relationships between the observed neurodegenerative disease and the affected proteasome subunits. (C) 2020 IMSS. Published by Elsevier Inc.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 50 条
  • [31] The ubiquitin proteasome system as a potential therapeutic target for treatment of neurodegenerative diseases
    Opattova, Alena
    Cente, Martin
    Novak, Michal
    Filipcik, Peter
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2015, 34 (04) : 337 - 352
  • [32] Amyloidosis and Neurodegenerative Diseases: Current Treatments and New Pharmacological Options
    Tillement, Jean-Paul
    Lecanu, Laurent
    Papadopoulos, Vassilios
    PHARMACOLOGY, 2010, 85 (01) : 1 - 17
  • [33] CRISPR/CAS9 GENOME EDITING FOR NEURODEGENERATIVE DISEASES
    Nojadeh, Jafar Nouri
    Eryilmaz, Nur Seren Bildiren
    Erguder, Berrin Imge
    EXCLI JOURNAL, 2023, 22 : 567 - 582
  • [34] Targeting Ubiquitin-Proteasome Pathway by Natural Products: Novel Therapeutic Strategy for Treatment of Neurodegenerative Diseases
    Momtaz, Saeideh
    Memariani, Zahra
    El-Senduny, Fardous F.
    Sanadgol, Nima
    Golab, Fereshteh
    Katebi, Majid
    Abdolghaffari, Amir Hossein
    Farzaei, Mohammad Hosein
    Abdollahi, Mohammad
    FRONTIERS IN PHYSIOLOGY, 2020, 11
  • [35] Role of axonal transport in neurodegenerative diseases
    De Vos, Kurt J.
    Grierson, Andrew J.
    Ackerley, Steven
    Miller, Christopher C. J.
    ANNUAL REVIEW OF NEUROSCIENCE, 2008, 31 : 151 - 173
  • [36] Promising Targets for the Treatment of Neurodegenerative Diseases
    Haeberlein, S. L. Budd
    Harris, T. J. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 98 (05) : 492 - 501
  • [37] Pyrimidine analogues for the management of neurodegenerative diseases
    Pant, Swati
    Kapri, Anandi
    Nain, Sumitra
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS, 2022, 6
  • [38] MicroRNAs in neurodegenerative diseases and their therapeutic potential
    Junn, Eunsung
    Mouradian, M. Maral
    PHARMACOLOGY & THERAPEUTICS, 2012, 133 (02) : 142 - 150
  • [39] Advances in Epigenetics and Epigenomics for Neurodegenerative Diseases
    Irfan A. Qureshi
    Mark F. Mehler
    Current Neurology and Neuroscience Reports, 2011, 11 : 464 - 473
  • [40] Stem Cells for the Treatment of Neurodegenerative Diseases
    Wu, Yong-Ping
    Chen, Wei-Shan
    Teng, Chong
    Zhang, Ning
    MOLECULES, 2010, 15 (10) : 6743 - 6758